Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
- Posted on July 11, 2025
- By CNBC
- 1 Views
Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.
